Severe cardiac AL amyloidosis in an elderly patient with multiple SARS-CoV-2 reinfection: a case report DOI Creative Commons
Е. В. Резник, T. L. Nguyen, О. А. Эттингер

et al.

Russian Journal of Cardiology, Journal Year: 2023, Volume and Issue: 28(8), P. 5443 - 5443

Published: Sept. 23, 2023

Introduction . The relationship between systemic amyloidosis and coronavirus disease 2019 (COVID-19) has not been sufficiently studied to date. This paper presents a case of the persistence COVID-19 markers in an elderly patient with amyloidosis. Brief description A 74-year-old heart failure preserved ejection fraction type 2 diabetes was repeatedly hospitalized due decompensated failure. Based on data protein electrophoresis immunotyping, biopsy subcutaneous fat bone marrow, echocardiographic data, diagnosed AL cardiac involvement. During hospitalizations April, August December 2020, positive polymerase chain reaction test for SARS-CoV-2 were obtained, while there no clinical manifestations infection long time adequate antibody production. Conclusion. report demonstrates multiple reinfection severe comorbid patient, as unfavorable prognostic factor.

Language: Английский

CARDIAC ARRHYTHMIA IN PATIENTS AFTER CORONAVIRUS INFECTION: FEATURES OF THE COURSE AND THERAPY DOI

I. Sergunina,

V. Malygina,

Е. Н. Голубева

et al.

Clinical Medicine and Pharmacology, Journal Year: 2023, Volume and Issue: 9(1), P. 27 - 30

Published: May 15, 2023

This paper presents data on the peculiarities of course and treatment rhythm disturbances in patients who have suffered a coronavirus infection cardiology department CHM "KB RZD-Medicine" Tula. Among all underwent therapy specialized for various kinds arrhythmias period from 2020 to 2022, 72% occurred after COVID-19. The most common arrhythmic consequences are supraventricular ventricular extrasystole, paroxysmal form tachycardia atrial fibrillation. Based analysis obtained by us, it was revealed that complex with use beta-blockers, cardioprotectors, sedatives, antiarrhythmic agents class I III has greatest effectiveness.

Language: Английский

Citations

0
Severe cardiac AL amyloidosis in an elderly patient with multiple SARS-CoV-2 reinfection: a case report DOI Creative Commons
Е. В. Резник, T. L. Nguyen, О. А. Эттингер

et al.

Russian Journal of Cardiology, Journal Year: 2023, Volume and Issue: 28(8), P. 5443 - 5443

Published: Sept. 23, 2023

Introduction . The relationship between systemic amyloidosis and coronavirus disease 2019 (COVID-19) has not been sufficiently studied to date. This paper presents a case of the persistence COVID-19 markers in an elderly patient with amyloidosis. Brief description A 74-year-old heart failure preserved ejection fraction type 2 diabetes was repeatedly hospitalized due decompensated failure. Based on data protein electrophoresis immunotyping, biopsy subcutaneous fat bone marrow, echocardiographic data, diagnosed AL cardiac involvement. During hospitalizations April, August December 2020, positive polymerase chain reaction test for SARS-CoV-2 were obtained, while there no clinical manifestations infection long time adequate antibody production. Conclusion. report demonstrates multiple reinfection severe comorbid patient, as unfavorable prognostic factor.

Language: Английский

Citations

0